Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2010
11/16/2010US7833798 Adjusting the pH of the sample solution to pH 4-9, and subjecting the sample solution to mass spectrometry or liquid chromatography
11/16/2010US7833797 Method of staining proteins using Alta
11/16/2010US7833796 used for the concentration, desalination, purification or stabilization of biological macromolecules and supramolecular structures, by means of superabsorbent polymers or superabsorptive composite materials.
11/16/2010US7833795 Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors
11/16/2010US7833794 Fecal sampling device and method
11/16/2010US7833793 Method and device for monitoring inhibition of platelet function
11/16/2010US7833792 test strip measuring method in which a coloration measurement is conducted while a test strip is being moved, there are detected the optical characteristics R of the ground of a test strip and the optical characteristics T of a test line which has appeared on the test strip, and the test strip ratios
11/16/2010US7833774 use of such proteins in isolating various types of attenuated viruses for the development of vaccine and pharmaceutical formulations; protocols utilizing interferon antagonists, e.g., NS1, to enhance gene therapy or DNA vaccination based on their ability to increase gene expression
11/16/2010US7833769 McrA variants and uses thereof
11/16/2010US7833746 Blood test instrument using a disposable cartridge
11/16/2010US7833745 rapid and efficient method for novel biological substance screening by surface analysis using Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS);
11/16/2010US7833740 by using monoclonal antibodies specific for SipC-protein; recognizes a wide variety of Salmonella, regardless of the specific serovar type
11/16/2010US7833738 Carbonic anhydrase (CA); enhance the efficacy of weak base chemotherapeutic drugs; positively charged sulfonamides that have membrane impermeability; diagnostic for cancer
11/16/2010US7833737 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents
11/16/2010US7833736 determining whether a mammalian cancer is likely to be resistant or responsive to OSI-930; reduces well-known side effects and are often of limited effect since they fail to specifically target the underlying causes of the malignancies
11/16/2010US7833735 Cell surface serine protease density as evaluative tool in detection of transplantation, autoimmunity, cancer and viral infection; monitoring of disease progression and pathologic phenomena that correlate with surface density of Human Leukocyte Elastase (HLE) associated with plasma membranes
11/16/2010US7833734 CA IX-specific inhibitors
11/16/2010US7833733 Methods for detecting and treating cancer
11/16/2010US7833732 Acute renal injury
11/16/2010US7833731 A protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance; kits
11/16/2010US7833730 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis
11/16/2010US7833729 detecting a test amount of an antibody that specifically binds to SEQ ID NO: 2 or SEQ ID NO: 4 polypeptide, comparing the test amount with a normal range of the antibody in a control sample; isolated Major Histocompatibility Complex (MHC)-peptide complex
11/16/2010US7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
11/16/2010US7833727 Increasing life span by modulation of Smek
11/16/2010US7833726 monoclonal antibody which has specific reactivity to an antigenic determinant site produced by reacting ADAMTS13 with VWF that is a substrate; Thrombotic thrombocytopenic purpura
11/16/2010US7833725 determining levels of glycated CD59 in subjects; permit a rapid and reliable measure; highly accurate and reproducible; diabetes
11/16/2010US7833724 Methods for comparing the immunogenicity of products and uses thereof
11/16/2010US7833723 Affinity chromatography matrices and methods of making and using the same
11/16/2010US7833722 Ligands for G protein-coupled receptor protein and use thereof
11/16/2010US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
11/16/2010US7833712 Diagnosis of lung cancer in mammals; obtain sample, extract nucleotide sequences, screen for methylated nucleotide sequences, compare methylation profile with healthy cells, evaluate for cancer; tumor suppressor lung cancer 1 (TSLC1)
11/16/2010US7833704 Methods for detecting aneuploidy using microparticle multiplex detection
11/16/2010US7833703 Method for the construction of randomized gene sequence libraries in cells
11/16/2010US7833701 Formed via enclosing biomolecules into microcapsules and spraying (via ink jets or bubble jets) onto substrate; biochips; solid phase synthesis; diagnostic networks
11/16/2010US7833699 Detection of tuberculosis and infection by Mycobacterium tuberculosis using HBHA
11/16/2010US7833698 Method for determining the response to cancer therapy
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/16/2010US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
11/16/2010US7833481 contact pad has a roll of sample collection sheets for collecting a trace sample, and exposure to the test medium, producing interaction between the test medium and the analyte of interest to produce a test result; photoluminescent analysis apparatus
11/16/2010US7833480 Oxygen monitoring apparatus and methods of using the apparatus
11/16/2010US7833438 Thermofluorescent pigments for security and safety applications
11/16/2010US7833395 Electrically conducting material pierced by a regular array of cavities; a measurement electrode formed of connected and electrically conducting microdisks, a generator electrode formed from an electrically conducting plate
11/16/2010US7833171 Method and apparatus for penetrating tissue
11/16/2010US7832585 Nine container per tray packaging configuration and method for enhanced cooling of produce
11/16/2010US7832295 Submersible probe apparatus for aqueous environment monitoring with new cam-twist interconnect, liquid barrier, and battery pack
11/16/2010CA2618852C Sample holder for dynamic light scattering
11/16/2010CA2581954C Portable apparatus for analysis of a refinery feedstock or a product of a refinery process
11/16/2010CA2573749C Immunological test element with improved control zone
11/16/2010CA2502657C Use of the green fluorescent protein as a screenable marker for plant transformation
11/16/2010CA2477618C Drift compensated magnetic permeability detector
11/16/2010CA2473708C A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2410439C A method for measuring hemoglobin concentration (hgb) in the blood in a circuit of a dialysis machine, measuring device and circuit for the application of the method
11/16/2010CA2401975C Fluid handling devices with diamond-like films
11/16/2010CA2297589C Energy transfer dyes with enhanced fluorescence
11/16/2010CA2278151C Heregulin variants
11/16/2010CA2215529C Carbohydrate-based vaccine and diagnostic reagent for trichinosis
11/15/2010CA2678775A1 Protein markers useful to differentiate immunized and infected specimens
11/14/2010CA2665599A1 Bacteriophage immobilization for biosensors
11/11/2010WO2010129959A1 Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna germline antibodies
11/11/2010WO2010129929A1 Selective protein labeling
11/11/2010WO2010129851A1 Methods of analyzing peptide mixtures
11/11/2010WO2010129821A1 Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
11/11/2010WO2010129797A1 Compositions comprising nanoparticles and apoptotic agents and methods of use
11/11/2010WO2010129787A2 Single molecule spectroscopy for analysis of cell-free nucleic acid biomarkers
11/11/2010WO2010129779A1 Methods for antimicrobial resistance determination
11/11/2010WO2010129713A2 Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject
11/11/2010WO2010129712A1 15-pgdh in colon cancer
11/11/2010WO2010129711A1 Devices, systems, and methods for evaluating vision and diagnosing and compensating impairment of vision
11/11/2010WO2010129656A2 Method of oligonucleotide labeling using cycloaddition reaction
11/11/2010WO2010129609A2 Antibodies and methods of use thereof
11/11/2010WO2010129564A1 Systems and methods for tailoring acute and chronic viral infection treatments to increase the probability of "cure" for a given subject
11/11/2010WO2010129558A1 Identification of swine-origin influenza a (h1n1) virus
11/11/2010WO2010129541A1 Emulsion selection of antibodies
11/11/2010WO2010129515A1 Modulation of the tgf-beta and pi3k/akt pathways in the diagnosis and treatment of squamous cell carcinoma
11/11/2010WO2010129477A1 Acid ceramidase polymorphisms and methods of predicting traits using the acid ceramidase polymorphisms
11/11/2010WO2010129441A2 Method for separating stem cells from their more differentiated progeny using microfluidic devices
11/11/2010WO2010129418A1 Lat adapter molecule for enhanced t-cell signaling and method of use
11/11/2010WO2010129386A2 Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)
11/11/2010WO2010129351A1 Method to identify and treat age-related macular degeneration
11/11/2010WO2010129302A1 Lateral-flow immuno-chromatographic assay devices
11/11/2010WO2010129283A2 Microfluidic analyte capture using a thermoflowable material
11/11/2010WO2010129270A2 Profiling fragments of elastic fibers and microfibrils as biomarkers for disease
11/11/2010WO2010129265A2 Compositions comprising monomeric streptavidin and methods for using same
11/11/2010WO2010129027A2 Analysis of membrane component interactions
11/11/2010WO2010128988A1 Human fg01 gene and its applications
11/11/2010WO2010128948A1 Method for the determination of p blood groups
11/11/2010WO2010128860A1 Method and system for the measurement/detection of chemical spillage
11/11/2010WO2010128742A1 Cancer diagnosis method using the glycosylation of a glycoprotein
11/11/2010WO2010128696A1 Composition for preventing and treating anxiety disorder, containing cholinergic enhancer
11/11/2010WO2010128657A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
11/11/2010WO2010128604A1 Silica nanoparticle having quantum dots encapsulated therein, method for producing same and biological labeling agent using same
11/11/2010WO2010128506A2 Means and methods for recognizing the development of cardiovascular disease in an individual
11/11/2010WO2010128464A1 Lung tissue model
11/11/2010WO2010128393A1 Method and composition for measuring the amount of vitamin d derivatives
11/11/2010WO2010128379A1 Fluid condition and level sensor
11/11/2010WO2010128322A1 Tagged scale inhibitors
11/11/2010WO2010128232A2 Method for diagnosing propionibacterium acnes infections
11/11/2010WO2010128221A1 Apparatus and disposable device for performing blood tests
11/11/2010WO2010128205A1 A lateral flow assay test strip and a method of making the same